Nuclear PRMT5, cyclin D1 and IL-6 are associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with p16-status.
about
Nuclear PRMT5, cyclin D1 and IL-6 are associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with p16-status.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nuclear PRMT5, cyclin D1 and I ...... ly associated with p16-status.
@en
Nuclear PRMT5, cyclin D1 and I ...... ly associated with p16-status.
@nl
type
label
Nuclear PRMT5, cyclin D1 and I ...... ly associated with p16-status.
@en
Nuclear PRMT5, cyclin D1 and I ...... ly associated with p16-status.
@nl
prefLabel
Nuclear PRMT5, cyclin D1 and I ...... ly associated with p16-status.
@en
Nuclear PRMT5, cyclin D1 and I ...... ly associated with p16-status.
@nl
P2093
P2860
P356
P1433
P1476
Nuclear PRMT5, cyclin D1 and I ...... ly associated with p16-status.
@en
P2093
Alessandra C Schmitt
Arti Yadav
Bhavna Kumar
Matthew Old
Michael J Cipolla
Nicole V Brown
Paul E Wakely
Pawan Kumar
Robert A Baiocchi
Songzhu Zhao
P2860
P304
14847-14859
P356
10.18632/ONCOTARGET.14682
P407
P577
2017-01-17T00:00:00Z